Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Panagiota G. Karagianni
Observed name:
P. Karagianni
Institution:
University of Ioannina
Observed institution:
University of Ioannina
ORCID:
0000-0001-6267-4658
Observed ORCID:
0000-0001-6267-4658
OpenAlex ID:
A5003341237
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
2021
·
Michalis P. Migkos
, Evripidis Kaltsonoudis
, et al.
·
Rheumatology International
·
15
PDF
State of the Art Review on the Treatment of Psoriatic Disease
2024
·
Eleftherios Pelechas
, Evripidis Kaltsonoudis
, et al.
·
Mediterranean Journal of Rheumatology
·
5
How to Make AI Ready for Rheumatology: Challenges and Perspectives
2025
·
Eleftherios Pelechas
, Panagiota G. Karagianni
, et al.
·
Mediterranean Journal of Rheumatology
·
3
PDF
The Clinical Significance and Therapeutic Management of Dactylitis and Enthesitis in Psoriatic Arthritis
2026
·
Eleftherios Pelechas
, Panagiota G. Karagianni
, et al.
·
Mediterranean Journal of Rheumatology
·
1
Abs0485 Psoriatic Arthritis Patients With Positive Anti-ccp and Rheumatoid Factor: a Unique Subset Responding Favorably to Il-6 Inhibitors
2025
·
E. Kaltsonoudis
, P. Karagianni
, et al.
·
Annals of the Rheumatic Diseases
Pos1194 the Effect of Sars-cov-2 on the Course and the Treatment of Rheumatic Inflammatory Diseases. Experience Form the Northwestern Greece
2021
·
E. Pelechas
, E. Kaltsonoudis
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
6
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type
